debrisoquin has been researched along with Glomerulonephritis in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böszörményi, E | 1 |
| Farsang, C | 1 |
| Morvai, V | 1 |
1 other study available for debrisoquin and Glomerulonephritis
| Article | Year |
|---|---|
Clinical observation with debrisoquinsulphate (Tendor) in essential hypertension and glomerulonephritis.
Topics: Adult; Aged; Debrisoquin; Female; Glomerulonephritis; Humans; Hypertension; Isoquinolines; Male; Mid | 1978 |